David Dibenedetto, MD
Interventional Pain Medicine · Waltham, MANPI 1770599029
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (34.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Eli Lilly accounts for 96.6% of it on its own, with 5 other manufacturers making up the rest.
Across 62 payments — averaging $270.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$16K
- AbbVie$214
- Nevro Corp.$136
- Amgen$123
- Pfizer$84
- SPR Therapeutics, Inc$17
Across 488 payments — averaging $43,229 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$18.9M
- Vertex$1.2M
- Teva Pharmaceuticals USA, Inc.$455K
- SPR Therapeutics, Inc$235K
- GSK$156K
- Nevro Corp.$53K
- plus $105K from 4 others
What the payments were for
- Consulting fees$5,75034%
- Speaking & faculty fees$5,47533%
- Travel & lodging$4,19725%
- Food & beverage$1,3278%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 41 | $16,176 |
| AbbVie | 13 | $214 |
| Nevro Corp. | 1 | $136 |
| Amgen | 1 | $123 |
| Pfizer | 5 | $84 |
| SPR Therapeutics, Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,749 in reported general payments places this provider in the 85th percentile of 22 interventional pain medicine providers in Massachusetts.
See all interventional pain medicine providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional pain medicine in Waltham
- Lee SilkWaltham$2K
- Nicholas BarnesWaltham$2K
- Warren Mackie-JenkinsBoston$65K
- Mark JonesBoston$48K
- Frederic GergesBoston$21K
- Anil KumarStoneham$8K
- Omar QureshiFitchburg$7K
- Rami RustumMethuen$6K
- Janet PearlFramingham$5K
- Yuri KhibkinHolyoke$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.